DUAVIVE 0,45 mg/20 mg Tabletten mit veränderter Wirkstofffreisetzung

Recall | Medicines | 25/05/2020

The marketing authorisation holder informed its customers on May 25, 2020 that the dissolution of an active substance may be slowed down and therefore the therapeutic effect may be delayed. So the affected batch is recalled.

Name of the medicinal product DUAVIVE 0,45 mg/20 mg Tabletten mit veränderter Wirkstofffreisetzung
Marketing authorisation number(s) EU/1/14/960/001
CIP code 4481048
Marketing authorisation holder Pfizer Europe MA EEIG
Batch number(s) AR3686
Classification of the recall 3
Depth of recall Wholesalers
BASG reference number INS-640.001-3205
keyboard_arrow_up to top